ANALYSIS OF THE RELATION BETWEEN ALOPECIA AND RESISTANCE TO 1,25‐DIHYDROXYVITAMIN D

Alopecia is a frequent feature in hereditary resistance to (1,25(OH)2D). We sought insight into this feature by analysing data from affected members of 30 kindreds. We assessed indices of mineral metabolism in one group with normal hair compared with a group with alopecia. Hereditary resistance to 1,25(OH)2D was diagnosed at an earlier age in alopecic patients (0·9 vs 3·3 years, P> 0·05); this reflected late presentation of metabolic bone disease in some cases with normal hair and could not be attributed to early diagnosis resulting from the striking feature of alopecia. For untreated subjects, serum concentrations of calcium and 1,25(OH)2D were similar in both groups of patients. During calciferol therapy, however, the cases with alopecia showed lower serum calcium (1·9 vs 2·4 mmol/1, P > 0·005), but higher serum 1,25(OH)2D (2900 v 340 pg/ml, P> 0·005). Hair status did not predict the type of defect identified with cultured skin fibroblasts but did correlate with responsiveness of 25(OH)D 24‐hydroxylase to 1,25(OH)2D3 in those cells. Cells from seven of eight kindreds with alopecia showed no 24‐hydroxylase response to high doses of 1,25(OH)2D3 while cells from five of six kindreds with normal hair showed a 24‐hydroxylase response to high doses of 1,25(OH)2D3. We conclude that in cases with hereditary resistance to 1,25(OH)2D alopecia reflects the more severe grades of this resistance based upon earlier age at time of diagnosis, lower potential for calcaemic response to calciferols, and lower potential for 24‐hydroxylase response to 1,25(OH)2D3 by cultured skin fibroblasts.

[1]  Manjunath.  Abstract 155: Vitamin D dependent rickets type II: Our experience and systematic review , 2022, Indian Journal of Endocrinology and Metabolism.

[2]  U. Liberman,et al.  Severely deficient binding of 1,25-dihydroxyvitamin D to its receptors in a patient responsive to high doses of this hormone. , 1986, The Journal of clinical endocrinology and metabolism.

[3]  Z. Hochberg,et al.  Calcitriol-resistant rickets with alopecia. , 1985, Archives of dermatology.

[4]  S. Marx,et al.  1200 MANIFESTATIONS OF 1,25-HYDROXYVITAMIN D RECEPTORS WITH ABNORMALLY LOW HORMONE AFFINITY: COMPARISON OF TWO KINDREDS , 1985, Pediatric Research.

[5]  D. Feldman,et al.  Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid. , 1985, The Journal of clinical endocrinology and metabolism.

[6]  U. Liberman,et al.  Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts. , 1985, The Journal of clinical investigation.

[7]  Z. Hochberg,et al.  1,25-Dihydroxyvitamin D resistance, rickets, and alopecia. , 1984, The American journal of medicine.

[8]  Z. Hochberg,et al.  1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents. , 1984, The Journal of clinical endocrinology and metabolism.

[9]  J. Adams,et al.  Specific internalization and action of 1,25-dihydroxyvitamin D3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia. , 1984, The Journal of clinical endocrinology and metabolism.

[10]  M. Haussler,et al.  Vitamin D3--resistant fibroblasts have immunoassayable 1,25-dihydroxyvitamin D3 receptors. , 1984, Science.

[11]  U. Liberman,et al.  Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects. , 1983, The Journal of clinical endocrinology and metabolism.

[12]  J. Zerwekh,et al.  Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3. , 1983, The Journal of clinical investigation.

[13]  B. Gilchrest,et al.  Interaction of 1,25-dihydroxyvitamin-D3 with keratinocytes and fibroblasts from skin of normal subjects and a subject with vitamin-D-dependent rickets, type II: a model for study of the mode of action of 1,25-dihydroxyvitamin D3. , 1983, The Journal of clinical endocrinology and metabolism.

[14]  U. Liberman,et al.  Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts. , 1983, The Journal of clinical investigation.

[15]  Z. Hochberg,et al.  Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3. , 1982, The Journal of clinical endocrinology and metabolism.

[16]  U. Liberman,et al.  A cellular defect in hereditary vitamin-D-dependent rickets type II: defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts. , 1981, The New England journal of medicine.

[17]  Z. Borochowitz,et al.  VITAMIN D RESISTANT RICKETS WITH ALOPECIA: A FORM OF END ORGAN RESISTANCE TO 1,25 DIHYDROXY VITAMIN D , 1981, Clinical endocrinology.

[18]  J. Saurat,et al.  Skin calcium binding protein is localized in the cytoplasm of the basal layer of the epidermis. , 1981, The Journal of investigative dermatology.

[19]  H. DeLuca,et al.  Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3. , 1980, The Journal of clinical endocrinology and metabolism.

[20]  D. Rotenstein.  Vitamin D-resistant rickets? , 1980, The Journal of pediatrics.

[21]  H. Orimo,et al.  An unusual form of vitamin D-dependent rickets in a child: alopecia and marked end-organ hyposensitivity to biologically active vitamin D. , 1980, The Journal of clinical endocrinology and metabolism.

[22]  T. Fujita,et al.  Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone. , 1980, The Journal of clinical endocrinology and metabolism.

[23]  N. Bell,et al.  Vitamin D-dependent rickets type II , 1980, Calcified Tissue International.

[24]  H. DeLuca,et al.  Vitamin D--resistant rickets: end-organ unresponsiveness to 1,25(OH)2D3. , 1980, The Journal of pediatrics.

[25]  J. Brooks.  Book ReviewGeneral Surgery , 1980 .

[26]  T. Clemens,et al.  END-ORGAN RESISTANCE TO 1,25-DIHYDROXYCHOLECALCIFEROL , 1980, The Lancet.

[27]  J. Zerwekh,et al.  An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. , 1979, The Journal of clinical endocrinology and metabolism.

[28]  H. DeLuca,et al.  Rickets with alopecia: an inborn error of vitamin D metabolism. , 1979, The Journal of pediatrics.

[29]  H. DeLuca,et al.  A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. , 1978, The Journal of clinical endocrinology and metabolism.

[30]  U. Liberman,et al.  Receptor-positive hereditary resistance to 1,25-dihydroxyvitamin D: chromatography of hormone-receptor complexes on deoxyribonucleic acid-cellulose shows two classes of mutation. , 1986, The Journal of clinical endocrinology and metabolism.

[31]  U. Liberman,et al.  Resistance to 1,25(OH)2D: Association with heterogeneous defects in cultured skin fibroblasts , 1983 .

[32]  M. Haussler,et al.  Receptor-positive resistance to 1,25-hydroxyvitamin D: A new cause of osteomalacia associated with impaired induction of 24-hydroxylase in fibroblasts , 1982 .